<DOC>
	<DOC>NCT01664013</DOC>
	<brief_summary>The purpose of this study is to investigate the impact of botulinum toxin treatment in quality of life(QoL) in cervical dystonia patients</brief_summary>
	<brief_title>The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>aged â‰¥ 18 years to 75 years Subjects requiring treatment for a clinical diagnosis of cervical dystonia Willing to provide written informed consent before any studyrelated procedures. Patients with pure anterocollis Patients with an anaphlyactic response history to botulinum toxin type A. Patients who have been treated with botulinum toxin type A within 3 month. Females who are pregnant, planning pregnancy, unable to use contraception or lactating. Any medical condition that may put the subject at increased risk with exposure to botulinum toxin at the discrimination of investigators.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>